期刊文献+

Preparation, optimization and in vitro evaluation of core-shell paclitaxelloaded nanoparticles composed of MPEG-PLA and PLA

载有紫杉醇的核-壳MPEG-PLA/PLA纳米微球的制备、优化及体外评价(英文)
原文传递
导出
摘要 Nanoparticles with typical core-shell structure were prepared with a blend of methoxypoly(ethylene glycol)-poly(lactide) copolymer (MPEG-PLA) and poly (lactic acid) (PLA) along with paclitaxel by the O/W solvent evaporation method. An orthogonal experiment L9(3)3 was applied to get the best preparation conditions. The core-shell paclitaxel-loaded MPEG-PLA/PLA nanoparticles with the highest drug loading efficiency were obtained when amount of MPEG-PLA, time of ultrasonication and volume of deionized water were 300 mg, 10 rain and 30 mL, respectively. The release behavior of paclitaxel from the optimal MPEG-PLA/PLA nanoparticles showed that 22% ofpaclitaxel was released in 14 d. When incubating with human nasopharyngeal carcinoma ceils expressing LMP 1, these optimal nanoparticles showed a little lower tumor growth compared with free paclitaxel. 本文制备了一种具有典型核-壳结构的载药纳米微球,由甲氧基聚乙二醇-聚乳酸共聚物(MPEG-PLA)、聚乳酸(PLA)和紫杉醇通过O/W溶剂挥发法制备而成。用正交试验L9(3)3对制备过程进行优化设计,当MPEG-PLA的用量为300 mg、超声时间为10 min、去离子水的用量为30 m L时可制得包封率最高的载有紫杉醇的MPEG-PLA/PLA纳米微球。体外溶出度实验表明14天后约有22%的紫杉醇从此微球中析出,体外抗肿瘤活性实验表明此微球对LMP1细胞具有略低于等量的游离紫杉醇的抗肿瘤活性。
出处 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2015年第2期104-110,共7页 中国药学(英文版)
基金 Key Research Foundation of Wannan Medical College(Grant No.WK2014Z06) Doctoral Starting-up Foundation of Wannan Medical College(Grant No.201219)
关键词 Core-shell nanoparticles MPEG-PLA/PLA PACLITAXEL Orthogonal design 核-壳结构纳米微球 甲氧基聚乙二醇-聚乳酸/聚乳酸 紫杉醇 正交设计
  • 相关文献

参考文献22

  • 1Kim, S.Y.; Lee, Y.M. Biomaterials. 2001, 22, 1697- 1704. 被引量:1
  • 2Zheng, H.; Hou, W.J.; Wang, J.C.; Zhang, Q. J. Chin. Pharm, Sci. 2012, 21,591-597. 被引量:1
  • 3Elsabahy, M.; Wooley, K.L. Chem. Soc. Rev. 2012, 41, 2545-2561. 被引量:1
  • 4Yu, M.K.; Park, J.; Jon, S. Theranostics. 2012, 2, 3-44. 被引量:1
  • 5Kataoka, K.; Harada, A.; Nagasaki, Y. Adv. Drug Deliv. Rev. 2001, 47, 113-131. 被引量:1
  • 6Li, Y.; Qi, X.R.; Maitani, Y.; Nagai, T. Nanotechnology. 2009, 20, 055106. 被引量:1
  • 7Quesnel, R.; Hildgen, P. Molecules. 2005, 10, 98-104. 被引量:1
  • 8Otsuka, H.; Naqasaki, Y.; Kataoka, K. Adv. Drug Deliv. Rev. 2003, 55, 403-419. 被引量:1
  • 9Schaedlich, A.; Rose, C.; Kuntsche, J.; Caysa, H.; Mueller, T.; Gopferich, A.; Mader, K. Pharm. Res. 2011, 28, 1995-2007. 被引量:1
  • 10Muranaka, M.; Hirota, K.; Ono, T. Mater. Lett. 2010, 64, 969-971. 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部